epros Gives Update On Androxal With Respect To Recent FDA Advisory Panel Outcome And Announces Upcoming Presentation at Biocentury
September 22, 2014 at 09:16 AM EDT
Repros Therapeutics Inc.® (Nasdaq: RPRX) today announced that the conclusions of the FDA Advisory Panel that met on Wednesday, September ...